[VYNE] YoY Quarter Result on 30-Sep-2020 [#Q3]

Stock
[VYNE] VYNE Therapeutics Inc.
Announcement Date
05-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 85.24%
YoY- -46.63%
Quarter Report
VYNE's Result
VYNE's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 114 167 4,086 3,269 0 0 909 -29.23%
PBT -6,071 -9,255 -21,285 -24,713 -16,855 -12,847 -8,172 -4.83%
Tax 513 204 3,439 1 0 0 0 -
NP -6,584 -9,459 -21,285 -24,714 -16,855 -12,847 -8,172 -3.53%
Tax Rate - - - - - - - -
Total Cost 6,698 9,626 25,371 27,983 16,855 12,847 9,081 -4.94%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin -5,775.44 -5,664.07 -520.93 -756.01 0.00 0.00 -899.01 36.32%
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -2.01 -2.94 -7.36 -10.61 -50.66 -40.26 -50.99 -41.64%
EPS Diluted -2.01 -2.94 -7.36 -10.61 -50.66 -40.26 -50.99 -41.64%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.